Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonists

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 5, 1999, Pages 1060-1065

  Bili, Androniki ^a,d   Condemi, John J ^a   Bottone, Susan M ^c   Ryan, Charlotte K ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Genesee Hospital   (United States)

^d STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

Asthma; Case series; Churg Strauss syndrome; Corticosteroids; Eosinophilia; Leukotriene receptor antagonists; Vasculitis

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; ASTHMA; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; FEMALE; HUMAN; MALE; PARANASAL SINUS; PRIORITY JOURNAL; VASCULITIS;

EID: 0032711608     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70089-8     Document Type: Article

References (15)

1. 1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951;27:277-301.
2. 2. Churg A, Brallas M, Cronin SR, Churg J. Formes frustes of Churg-Strauss syndrome. Chest 1995;108:320-3.
3. 3. Lie JT. Limited forms of Churg-Strauss syndrome. Pathol Annu 1993;28:199-220.
4. 4. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984;63:65-81.
5. 5. Masi AT, Hunder GG, Lie JT, Michael BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg Strauss syndrome (allergic granulomatosis and vasculitis). Arthritis Rheum 1990;33:1094-100.
6. 6. Wechsler ME, Garpestad E, Flier SR, Kocher O, Weiland DA, Polito AJ, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998;279:455-7.
7. 7. Katz RS, Papernik M. Zafirlukast and Churg-Strauss syndrome [letter]. JAMA 1998;279:1949.
8. 8. Green RL, Vayonis AG. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet 1999;353:725-6.
9. 9. Knoell DL, Lucas J, Allen JN. Churg-Strauss syndrome associated with zafirlukast. Chest 1998;114:332-4.
10. 10. Kinoshita M, Shiraishi T, Koga T, Ayabe M, Rikimaru T, Oizumi K. Churg-Srauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol 1999;103:534-5.
11. 11. Rao JK, Allen NB, Pincus T. Limitations of 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998;129:345-52.
12. 12. Churg A, Churg J. Steroids and Churg-Strauss syndrome. Lancet 1998;352:32-3.
13. 13. Lie JT. The classification of vasculitis and a reappraisal of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Mt Sinai J Med 1986;53:429-39.
14. 14. Guillevin L, Visser H, Noel LH, Pourpat J, Vernier I, Gayraud M, et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome - 62 patients. J Rheumatol 1993;20:1354-9.
15. 15. Watts RA, Carruthers DM, Scott DGI. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995;25:28-34.